Jean-Philippe Combal, Vivet Therapeutics CEO, will participate to a round table during the Market Access for Cell & Gene Therapies conference in London Oct. 18-19. The round table is entitled "Preferred payment models for cell and gene therapies" and will be held at 10am on Oct. 19